My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

CVS Health Corp (NY:CVS)

77.72 -0.07 (-0.09%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CVS Health Corp

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

58 59 Next >

3 Dow Stocks to Sell in September Before They Crash and Burn ↗

September 04, 2023

Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell.

Via InvestorPlace

Topics Stocks

Looking Into CVS Health's Recent Short Interest ↗

September 04, 2023

Via Benzinga

Amazon Stock ‘Has Something For Everyone’ - Gina Sanchez ↗

September 03, 2023

Via Talk Markets

2 Underappreciated Dividend Stocks to Buy in September and Hold Forever ↗

September 03, 2023

After falling significantly in recent weeks, these excellent dividend stocks look like screaming buys.

Via The Motley Fool

Could CVS Make a Copy of Ozempic? ↗

September 02, 2023

Given its new biosimilars unit, copying Ozempic is more likely than it sounds.

Via The Motley Fool

11 Analysts Have This to Say About CVS Health ↗

September 01, 2023

Via Benzinga

Check Out What Whales Are Doing With CVS ↗

August 29, 2023

Via Benzinga

CVS Health Unusual Options Activity For August 21 ↗

August 21, 2023

Via Benzinga

Looking At CVS Health's Recent Unusual Options Activity ↗

August 18, 2023

Via Benzinga

Is CVS Stock a Buy After the Recent Drop? ↗

August 18, 2023

CVS stock is down close to 30% this year, and I believe it might be a steal for dividend investors.

Via The Motley Fool

CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know ↗

September 01, 2023

CVS just fired a shot across Viatris' bow.

Via The Motley Fool

CVS Just Made a Major New Announcement, But Should You Buy It? ↗

September 01, 2023

Spinning up a new division will probably be a boon for shareholders.

Via The Motley Fool

Is Federal Realty Investment Trust a Buy? ↗

September 01, 2023

It's a great company, but the yield is nothing special.

Via The Motley Fool

3 Undervalued Healthcare Stocks In 2023 ↗

August 31, 2023

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

Via Talk Markets

Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity ↗

August 29, 2023

If you're looking for a once-in-a-lifetime investment opportunity, consider these seven blue-chip stocks to buy now.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

August 28, 2023

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields ↗

August 28, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Boeing's 737 Deliveries Delay Due To Supplier Spirit Aerosystems, Petco Health and Wellness Stock Tumbles, AstraZeneca Under Legal Lens: Today's Top Stories ↗

August 24, 2023

Benzinga

Via Benzinga

Topics Supply Chain

Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz ↗

August 24, 2023

CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar

Via Benzinga

CVS Health's Earnings Crashed 37% in Q2: Should Investors Be Worried? ↗

August 24, 2023

The badly beaten-up stock is now trading near its 52-week low.

Via The Motley Fool

2 Beaten-Down Dividend Stocks That Look Like Bargains Now ↗

August 24, 2023

Both these stocks are down this year, but the dividends they distribute are most likely on the way up.

Via The Motley Fool

3 Pharma Stocks to Buy as Summer COVID Cases Spike ↗

August 23, 2023

Covid cases are on the rise, which might be the booster shot these top pharma stocks for Covid need to regain their trajectory.

Via InvestorPlace

Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends ↗

August 22, 2023

Via Benzinga

Tesla, Nvidia Surge By Same Value As Goldman Sachs, Starbucks In 1 Day ↗

August 21, 2023

When people on Wall Street call companies like NVIDIA Corp (NASDAQ: NVDA) and Tesla Inc (NASDAQ: TSLA) tech giants, they really aren’t kidding about the giant part.

Via Benzinga

Want to Get Rich? 3 Game-Changing Stocks to Buy Right Now ↗

August 18, 2023

Dive into the realm of high-potential stocks, and discover what "Stocks to Buy to Get Rich" truly means in the modern market.

Via InvestorPlace

CVS Stock Price Predictions: What to Know as Analysts Cut CVS Price Targets ↗

August 18, 2023

Although a major insurer announced a reduction in reliance on CVS Health, analysts largely remain unmoved with CVS stock.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023 ↗

August 18, 2023

Via Benzinga

Stock Market Correction Takes Hold As Treasury Yields Hit 15-Year High: Weekly Review ↗

August 18, 2023

The major indexes and leading stocks broke key support this week.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 17, 2023

Via Benzinga

Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 17, 2023

Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.